Giant cell arteritis: Clinical features of patients visiting a headache clinic in Japan

Internal Medicine

Volumn 50, Issue 16, 2011, Pages 1679-1682

  Imai, Noboru ^a   Kuroda, Ryou ^a   Konishi, Takashi ^a   Serizawa, Masahiro ^a   Kobari, Masahiro ^a  

^a SHIZUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Giant cell arteritis; Jaw claudication; Polymyalgia rheumatica; Visual loss

Indexed keywords

PREDNISOLONE;

AGED; ANGIOGRAPHY; ARTICLE; BLINDNESS; BLOOD VESSEL BIOPSY; BRAIN INFARCTION; CAUSE OF DEATH; CLAUDICATION; CLINICAL ARTICLE; CLINICAL FEATURE; DEMENTIA; DIGESTIVE SYSTEM ULCER; DRUG EFFICACY; FEMALE; GIANT CELL ARTERITIS; HEADACHE; HUMAN; HUMAN TISSUE; INFECTION; JAW PAIN; MALE; NERVE PARALYSIS; OTALGIA; PROGNOSIS; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; TRIGEMINAL NERVE;

AGED; AGED, 80 AND OVER; FEMALE; GIANT CELL ARTERITIS; HEADACHE; HUMANS; JAPAN; MALE; OUTPATIENT CLINICS, HOSPITAL; RETROSPECTIVE STUDIES;

EID: 84860389107     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5205     Document Type: Article

References (16)

1. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 372: 234-245, 2008.
2. Haugeberg G, Paulsen PQ, Bie RB. Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol 27: 2624-2627, 2000.
3. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 51: 264-268, 2004.
4. Chaudhry IA, Shamsi FA, Elzaridi E, Arat YO, Bosley TM, Riley FC. Epidemiology of giant-cell arteritis in an Arab population: a 22-year study. Br J Ophthalmol 91: 715-718, 2007.
5. Pamuk ON, Donmez S, Karahan B, Pamuk GE, Cakir N. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data. Clin Exp Rheumatol 27: 830-833, 2009.
6. Kobayashi S, Yano T, Matsumoto Y, et al. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 49: 594-598, 2003.
7. Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia 28: 1188-1195, 2008.
8. Tanganelli P. Secondary headaches in the elderly. Neurol Sci 31 (Suppl 1): S73-S76, 2010.
9. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33: 1122-1128, 1990.
10. City of Shizuoka. Population and household in Shizuoka City. Available at: http://www.city.shizuoka.jp/deps/joho/tokei_hp-jinkou_jyuki_j-index.html (in Japanese).
11. Okuno H, Imai N, Konishi T, Suzuki Y, Serizawa M, Okabe T. Temporal arteritis repeatedly associated with cranial neuropathies. Nippon Naika Gakkai Zasshi 95: 939-941, 2006 (in Japanese).
12. Hunder GG. Giant-cell arteritis and polymyalgia rheumatica. In: Textbook of Rheumatology. Kelly WN, Harris ED Jr, Ruddy S, Sledge CB, Eds. WB Saunders, Philadelphia, 1993: 1103-1112.
13. Aiello PD, Trautman JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology 100: 550-555, 1993.
14. Font C, Cid MC, Coll-Vincent B, López-Soto A, Grau JM. Clinical features in patients with permanent visual loss due to biopsyproven giant cell arteritis. Br J Rheumatol 36: 251-254, 1997.
15. Cid MC, Font C, Oristrell J, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 41: 26-32, 1998.
16. Khalifa M, Karmani M, Jaafoura NG, Kaabia N, Letaief AO, Bahri F. Epidemiological and clinical features of giant cell arteritis in Tunisia. Eur J Intern Med 20: 208-212, 2009.